'No tolerance for failure': An oral history of the first CRISPR medicine

BioPharma

Related Keywords

Boston ,Massachusetts ,United States ,Stanford University ,California ,Berkeley ,New York ,Nessan Bermingham ,Tirtha Chakraborty ,Shaun Foy ,Simeon George ,Stuart Arbuckle ,Sam Kulkarni ,Jerel Davis ,Feng Zhang ,Rodger Novak ,Emmanuelle Charpentier ,Haydar Frangoul ,Stuart Orkin ,Rachel Haurwitz ,Bastiano Sanna ,David Altshuler ,Jennifer Doudna ,John Maraganore ,Us Senate ,Atlas Venture ,Alnylam Pharmaceuticals ,Sarah Cannon Research Institute ,Vertex Pharmaceuticals ,Broad Institute ,Office Of Science ,New York Times ,Regulatory Agency ,Novartis ,University Of California ,Sangamo Biosciences ,Harvard Medical School ,Caribou Biosciences ,Editas Medicine ,Technology Policy ,Intellia Therapeutics ,Jeff Leiden ,Boston Children ,Vor Biopharma ,Mass General ,Gene Therapy ,